ArticleJournal of translational medicine2025
OncoMet: a deep learning framework for the prediction of oncogenic signaling pathways and metastasis in esophageal cancer patients using histopathology images from primary tumors.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial Intelligence for Molecular Biomarker Identification in Gastrointestinal and Hepatobiliary Cancers.International journal of molecular sciences · 2026Review
- Machine learning applications in the detection and treatment of esophageal cancer.Discover oncology · 2026Review
- Identification of serum 5'tRF-Val as a promising non-invasive biomarker for early detection of esophageal cancer.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundDespite recent advancements in the diagnosis and prognosis of Esophageal cancer (EC), it remains among the leading causes of cancer-related mortality. Timely and cost-effective diagnosis, particularly in predicting the risk of metastasis and identifying the deregulation of oncogenic signaling pathways, could open new frontiers towards precision medicine and targeted therapy of EC. However, current diagnostic practices in identifying metastasis and deregulated oncogenic pathways involve molecular testing, which is time-consuming and costly. Advances in deep learning analysis of digital pathological imagery data offer promising avenues for automating and enhancing cancer diagnosis and risk stratification.
methodsHigh-resolution H&E-stained diagnostic whole slide images were obtained from the open repository of The Cancer Genome Atlas (TCGA). The WSIs underwent several pre-processing steps, including patching, color normalization and augmentation. A deep learning model was designed and trained on WSI data and tissue-level labels to generate image feature representations for predicting metastatic potential and identifying the deregulation of four major oncogenic signaling pathways, viz. mTOR, PTEN, p53, and PI3K/AKT.
resultsThe proposed model achieved an AUC of 0.92 for predicting metastatic risk and AUCs ranging from 0.64 to 0.92 for the identification of deregulated oncogenic pathways. In a first, we were able to operate the model without the need for exhaustive patch-level annotations, relying instead on slide-level annotations only.
conclusionIn this work, we highlighted the transformative potential of deep learning in accurately detecting metastasis and identifying deregulated oncogenic pathways from H&E slides using slide-level annotation, thus opening new doors in precision medicine and targeted therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.